Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982592priorityCriticalpatent/ECSP982592A/en
Publication of ECSP982592ApublicationCriticalpatent/ECSP982592A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
Un método para el tratamiento de diabetes mellitus y condiciones asociadas con diabetes mellitus en un mamífero, cuyo método comprende administrar una cantidad eficaz no tóxica y farmacéuticamente aceptable de un agente antihiperglucémico inhibidor de alfa-glucosidasa, a un mamífero que necesita del mismo, y una composición para su uso en dicho método.A method for treating diabetes mellitus and conditions associated with diabetes mellitus in a mammal, the method of which comprises administering a non-toxic and pharmaceutically acceptable effective amount of an alpha-glucosidase inhibiting antihyperglycemic agent, to a mammal in need thereof, and a composition for use in said method.
ECSP9825921998-07-161998-07-16
NEW METHOD OF TREATMENT V
ECSP982592A
(en)
PHARMACEUTICAL COMPOSITION FOR A SUBJECT WHO NEEDS AN ELEVATION OF THE CONTENT OF NAD INTRACELLULAR, AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE TO INCREASE THE PROTECTIVE CELLULAR RESPONSES TO GENOTOXIC STRESS IN THE SKIN